The global market for Human Vaccines was valued at US$46.9 Billion in 2024 and is projected to reach US$71.4 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. This comprehensive report ...

Introduction The COVID-19 pandemic is expected to have impacted many drivers of antimicrobial resistance (AMR) and compounded ...

Food and Drug Administration officials say they will ratchet up requirements for vaccine studies, citing concerns about COVID shots for kids. But public health experts question the agency's analysis.

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...

Upstate Global Health Director Dr. Stephen Thomas discussed the current flu season trends and concerns, the importance of ...

Moderna’s nearly $20 billion cash hoard has dwindled to a single-digit stash following a series of setbacks for the biotech.

Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up to 10% revenue ...

Flu vaccines are crucial tools in protecting public health by reducing the risk of influenza illness and its complications.

A mutated strain of the flu is surging worldwide, sparking concerns about a severe flu season in the U.S. Here's what to ...

Out on his farm in Dundee Township, Cliff McConville sees geese landing in the fields where his turkeys and chickens graze. It's a sight that often unnerves poultry producers, as migratory waterfowl ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...